A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.

New treatment options may make "no evidence of disease activity" (NEDA: no relapses or disability progression and no new/enlarging MRI lesions, as opposed to "evidence of disease activity" (EDA) with at least one of the former), an achievable goal in relapsing-remitting multiple...

Full description

Bibliographic Details
Main Authors: Gro O Nygaard, Elisabeth G Celius, Sigrid A de Rodez Benavent, Piotr Sowa, Marte W Gustavsen, Anders M Fjell, Nils I Landrø, Kristine B Walhovd, Hanne F Harbo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0135974